Skip to main content
SpringerLink
Log in

Fatty Acid Oxidation Disorders

  • Chapter
  • First Online:
Nutrition Management of Inherited Metabolic Diseases

  • 964 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006;142C(2):77–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Baruteau J, Sachs P, Broue P, Brivet M, Abdoul H, Vianey-Saban C, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis. 2013;36(5):795–803.

    Article  CAS  PubMed  Google Scholar 

  3. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr. 1998;132(6):924–33.

    Article  CAS  PubMed  Google Scholar 

  4. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem. 2001;47(7):1166–82.

    Article  CAS  PubMed  Google Scholar 

  5. Nennstiel-Ratzel U, Arenz S, Maier EM, Knerr I, Baumkotter J, Roschinger W, et al. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening. Mol Genet Metab. 2005;85(2):157–9.

    Article  CAS  PubMed  Google Scholar 

  6. Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010;156(3):492–4.

    Article  CAS  PubMed  Google Scholar 

  7. Emken EA, Adlof RO, Rohwedder WK, Gulley RM. Influence of linoleic acid on desaturation and uptake of deuterium-labeled palmitic and stearic acids in humans. Biochim Biophys Acta. 1993;1170(2):173–81.

    Article  CAS  PubMed  Google Scholar 

  8. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64:477–502.

    Article  CAS  PubMed  Google Scholar 

  9. Turnbull DM, Bartlett K, Stevens DL, Alberti KG, Gibson GJ, Johnson MA, et al. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med. 1984;311(19):1232–6.

    Article  CAS  PubMed  Google Scholar 

  10. Stanley CA, Hale DE, Coates PM, Hall CL, Corkey BE, Yang W, et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res. 1983;17(11):877–84.

    Article  CAS  PubMed  Google Scholar 

  11. Eder M, Krautle F, Dong Y, Vock P, Kieweg V, Kim JJ, et al. Characterization of human and pig kidney long-chain-acyl-CoA dehydrogenases and their role in beta-oxidation. Eur J Biochem. 1997;245(3):600–7.

    Article  CAS  PubMed  Google Scholar 

  12. Aoyama T, Ueno I, Kamijo T, Hashimoto T. Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene product, is a rate-limiting enzyme in long-chain fatty acid beta-oxidation system. cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem. 1994;269(29):19088–94.

    Article  CAS  PubMed  Google Scholar 

  13. Derks TG, Reijngoud DJ, Waterham HR, Gerver WJ, van den Berg MP, Sauer PJ, et al. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr. 2006;148(5):665–70.

    Article  CAS  PubMed  Google Scholar 

  14. Mayell SJ, Edwards L, Reynolds FE, Chakrapani AB. Late presentation of medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2007;30(1):104.

    Article  CAS  PubMed  Google Scholar 

  15. Wilhelm GW. Sudden death in a young woman from medium chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. J Emerg Med. 2006;30(3):291–4.

    Article  PubMed  Google Scholar 

  16. Raymond K, Bale AE, Barnes CA, Rinaldo P. Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman. Genet Med. 1999;1(6):293–4.

    Article  CAS  PubMed  Google Scholar 

  17. Mayatepek E, Koch HG, Hoffmann GF. Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1997;20(6):842–3.

    Article  CAS  PubMed  Google Scholar 

  18. Davidson-Mundt A, Luder AS, Greene CL. Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1992;120(3):444–6.

    Article  CAS  PubMed  Google Scholar 

  19. Ibdah JA, Dasouki MJ, Strauss AW. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia. J Inherit Metab Dis. 1999;22(7):811–4.

    Article  CAS  PubMed  Google Scholar 

  20. Strauss AW, Bennett MJ, Rinaldo P, Sims HF, O’Brien LK, Zhao Y, et al. Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications. Semin Perinatol. 1999;23(2):100–12.

    Article  CAS  PubMed  Google Scholar 

  21. Mathur A, Sims HF, Gopalakrishnan D, Gibson B, Rinaldo P, Vockley J, et al. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation. 1999;99(10):1337–43.

    Article  CAS  PubMed  Google Scholar 

  22. Cox GF, Souri M, Aoyama T, Rockenmacher S, Varvogli L, Rohr F, et al. Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1998;133(2):247–53.

    Article  CAS  PubMed  Google Scholar 

  23. Brown-Harrison MC, Nada MA, Sprecher H, Vianey-Saban C, Farquhar J Jr, Gilladoga AC, et al. Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy. Biochem Mol Med. 1996;58(1):59–65.

    Article  CAS  PubMed  Google Scholar 

  24. Cavicchi C, Donati M, Parini R, Rigoldi M, Bernardi M, Orfei F, et al. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-clues for early diagnosis and timely treatment. Orphanet J Rare Dis. 2014;9:105.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Choong K, Clarke JT, Cutz E, Pollit RJ, Olpin SE. Lethal cardiac tachyarrhythmia in a patient with neonatal carnitine-acylcarnitine translocase deficiency. Pediatr Dev Pathol. 2001;4(6):573–9.

    Article  CAS  PubMed  Google Scholar 

  26. Bonnet D, Martin D, Pascale De L, Villain E, Jouvet P, Rabier D, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100(22):2248–53.

    Article  CAS  PubMed  Google Scholar 

  27. El-Gharbawy A, Vockley J. Inborn errors of metabolism with myopathy: defects of fatty acid oxidation and the carnitine shuttle system. Pediatr Clin N Am. 2018;65(2):317–35.

    Article  Google Scholar 

  28. Fletcher JM, Pitt JJ. Fasting medium chain acyl-coenzyme a dehydrogenase--deficient children can make ketones. Metabolism. 2001;50(2):161–5.

    Article  CAS  PubMed  Google Scholar 

  29. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13(3):321–4.

    Article  CAS  PubMed  Google Scholar 

  30. Van Hove JL, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet. 1993;52(5):958–66.

    PubMed  PubMed Central  Google Scholar 

  31. Bonnefont JP, Specola NB, Vassault A, Lombes A, Ogier H, de Klerk JB, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr. 1990;150(2):80–5.

    Article  CAS  PubMed  Google Scholar 

  32. Costa CC, de Almeida IT, Jakobs C, Poll-The BT, Duran M. Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res. 1999;46(4):440–4.

    Article  CAS  PubMed  Google Scholar 

  33. Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem. 2001;47(10):1763–8.

    Article  CAS  PubMed  Google Scholar 

  34. Hesse J, Braun C, Behringer S, Matysiak U, Spiekerkoetter U, Tucci S. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD). J Inherit Metab Dis. 2018;41(6):1169–78.

    Article  CAS  PubMed  Google Scholar 

  35. Hoffmann L, Haussmann U, Mueller M, Spiekerkoetter U. VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment. J Inherit Metab Dis. 2012;35(2):269–77.

    Article  CAS  PubMed  Google Scholar 

  36. Wanders RJ, Ruiter JP, IJLst L, Waterham HR, Houten SM. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results. J Inherit Metab Dis. 2010;33(5):479–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Andresen BS, Olpin S, Poorthuis BJ, Scholte HR, Vianey-Saban C, Wanders R, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet. 1999;64(2):479–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Coughlin CR 2nd, Ficicioglu C. Genotype-phenotype correlations: sudden death in an infant with very-long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2010;33 Suppl 3:S129–31.

    Article  PubMed  Google Scholar 

  39. Sander S, Janzen N, Janetzky B, Scholl S, Steuerwald U, Schafer J, et al. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany). Eur J Pediatr. 2001;160(5):318–9.

    Article  CAS  PubMed  Google Scholar 

  40. Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet. 2002;3:17–45.

    Article  CAS  PubMed  Google Scholar 

  41. Rinaldo P, Raymond K, al-Odaib A, Bennett MJ. Clinical and biochemical features of fatty acid oxidation disorders. Curr Opin Pediatr. 1998;10(6):615–21.

    Article  CAS  PubMed  Google Scholar 

  42. Heales SJ, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV. Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1994;17(1):74–80.

    Article  CAS  PubMed  Google Scholar 

  43. Anderson DR, Viau K, Botto LD, Pasquali M, Longo N. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2020;129(1):13–9.

    Article  CAS  PubMed  Google Scholar 

  44. Ruitenbeek W, Poels PJ, Turnbull DM, Garavaglia B, Chalmers RA, Taylor RW, et al. Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry. 1995;58(2):209–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Arens R, Gozal D, Jain K, Muscati S, Heuser ET, Williams JC, et al. Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome. J Pediatr. 1993;122(5 Pt 1):715–8.

    Article  CAS  PubMed  Google Scholar 

  46. Gregersen N, Winter V, Curtis D, Deufel T, Mack M, Hendrickx J, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. Hum Hered. 1993;43(6):342–50.

    Article  CAS  PubMed  Google Scholar 

  47. Andresen BS, Dobrowolski SF, O’Reilly L, Muenzer J, McCandless SE, Frazier DM, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001;68(6):1408–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Derks TG, van Spronsen FJ, Rake JP, van der Hilst CS, Span MM, Smit GP. Safe and unsafe duration of fasting for children with MCAD deficiency. Eur J Pediatr. 2007;166(1):5–11.

    Article  PubMed  Google Scholar 

  49. Yusupov R, Finegold DN, Naylor EW, Sahai I, Waisbren S, Levy HL. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening. Mol Genet Metab. 2010;101(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  50. IJlst L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest. 1996;98(4):1028–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, et al. Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest. 1995;95(5):2076–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Ushikubo S, Aoyama T, Kamijo T, Wanders RJ, Rinaldo P, Vockley J, et al. Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits. Am J Hum Genet. 1996;58(5):979–88.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Fletcher AL, Pennesi ME, Harding CO, Weleber RG, Gillingham MB. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2012;106(1):18–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. den Boer ME, Wanders RJ, Morris AA, IJlst L, Heymans HS, Wijburg FA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109(1):99–104.

    Article  Google Scholar 

  55. Gillingham MB, Weleber RG, Neuringer M, Connor WE, Mills M, van Calcar S, et al. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab. 2005;86(1–2):124–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ibdah JA, Tein I, Dionisi-Vici C, Bennett MJ, IJlst L, Gibson B, et al. Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation. J Clin Invest. 1998;102(6):1193–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Yang Z, Yamada J, Zhao Y, Strauss AW, Ibdah JA. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA. 2002;288(17):2163–6.

    Article  PubMed  Google Scholar 

  58. Van Hove JL, Kahler SG, Feezor MD, Ramakrishna JP, Hart P, Treem WR, et al. Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency. J Inherit Metab Dis. 2000;23(6):571–82.

    Article  PubMed  Google Scholar 

  59. Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM. Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology. 1994;44(3 Pt 1):467–73.

    Article  CAS  PubMed  Google Scholar 

  60. Schymik I, Liebig M, Mueller M, Wendel U, Mayatepek E, Strauss AW, et al. Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. J Pediatr. 2006;149(1):128–30.

    Article  CAS  PubMed  Google Scholar 

  61. Boneh A, Andresen BS, Gregersen N, Ibrahim M, Tzanakos N, Peters H, et al. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab. 2006;88(2):166–70.

    Article  CAS  PubMed  Google Scholar 

  62. Sahai I, Bailey JC, Eaton RB, Zytkovicz T, Harris DJ. A near-miss: very long chain acyl-CoA dehydrogenase deficiency with normal primary markers in the initial well-timed newborn screening specimen. J Pediatr. 2011;158(1):172; author reply -3.

    Article  PubMed  Google Scholar 

  63. Spiekerkoetter U, Mueller M, Sturm M, Hofmann M, Schneider DT. Lethal undiagnosed very long-chain acyl-CoA dehydrogenase deficiency with mild C14-Acylcarnitine abnormalities on Newborn screening. JIMD Rep. 2012;6:113–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Arnold GL, Van Hove J, Freedenberg D, Strauss A, Longo N, Burton B, et al. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2009;96(3):85–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Spiekerkoetter U, Sun B, Zytkovicz T, Wanders R, Strauss AW, Wendel U. MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency. J Pediatr. 2003;143(3):335–42.

    Article  PubMed  Google Scholar 

  66. Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner MR, Boehles H, et al. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis. 2009;32(4):498–505.

    Article  CAS  PubMed  Google Scholar 

  67. Gillingham MB, Heitner SB, Martin J, Rose S, Goldstein A, El-Gharbawy AH, et al. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial. J Inherit Metab Dis. 2017;40(6):831–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev. 1980;60(1):143–87.

    Article  CAS  PubMed  Google Scholar 

  69. Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA. Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997;337(17):1203–7.

    Article  CAS  PubMed  Google Scholar 

  70. Aledo R, Zschocke J, Pie J, Mir C, Fiesel S, Mayatepek E, et al. Genetic basis of mitochondrial HMG-CoA synthase deficiency. Hum Genet. 2001;109(1):19–23.

    Article  CAS  PubMed  Google Scholar 

  71. Korman SH. Inborn errors of isoleucine degradation: a review. Mol Genet Metab. 2006;89(4):289–99.

    Article  CAS  PubMed  Google Scholar 

  72. Sovik O. Mitochondrial 2-methylacetoacetyl-CoA thiolase deficiency: an inborn error of isoleucine and ketone body metabolism. J Inherit Metab Dis. 1993;16(1):46–54.

    Article  CAS  PubMed  Google Scholar 

  73. Abdelkreem E, Harijan RK, Yamaguchi S, Wierenga RK, Fukao T. Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency. Hum Mutat. 2019;40(10):1641–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Fukao T, Mitchell G, Sass JO, Hori T, Orii K, Aoyama Y. Ketone body metabolism and its defects. J Inherit Metab Dis. 2014;37(4):541–51.

    Article  CAS  PubMed  Google Scholar 

  75. Fukao T, Sass JO, Kursula P, Thimm E, Wendel U, Ficicioglu C, et al. Clinical and molecular characterization of five patients with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency. Biochim Biophys Acta. 2011;1812(5):619–24.

    Article  CAS  PubMed  Google Scholar 

  76. Fukao T, Mitchell GA, Song XQ, Nakamura H, Kassovska-Bratinova S, Orii KE, et al. Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics. 2000;68(2):144–51.

    Article  CAS  PubMed  Google Scholar 

  77. van Hasselt PM, Ferdinandusse S, Monroe GR, Ruiter JP, Turkenburg M, Geerlings MJ, et al. Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med. 2014;371(20):1900–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Professor Johan Van Hove from the University of Colorado who authored the initial version of this chapter on fatty acid oxidation disorders and for his mentorship on fatty acid oxidation disorders and the importance of anabolism in general.

Author information

Authors and Affiliations

  1. Clinical Genetics and Metabolism, Children’s Hospital Colorado, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO, USA

    Curtis R. Coughlin II

Authors
  1. Curtis R. Coughlin II
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Curtis R. Coughlin II .

Editor information

Editors and Affiliations

  1. Children’s Hospital Colorado, University of Colorado Hospital, Aurora, CO, USA

    Laurie E. Bernstein

  2. Met Ed Co, Boulder, CO, USA

    Fran Rohr

  3. Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA

    Sandy van Calcar

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Coughlin, C.R. (2022). Fatty Acid Oxidation Disorders. In: Bernstein, L.E., Rohr, F., van Calcar, S. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-94510-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94510-7_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94509-1

  • Online ISBN: 978-3-030-94510-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation